Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00743470 · ClinicalTrials.gov registry record · Phase 1
A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
A Phase 1 study, sponsored by Abbott.
- Terminated
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT00743470 is a Phase 1 study that was terminated before completion, run by Abbott. The registered enrollment target is 15 participants.
The verdict
NCT00743470, a Phase 1 study, was terminated before completion, sponsored by Abbott.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to study the safety, tolerability and pharmacokinetics of rifabutin dosing with lopinavir/ritonavir tablets in healthy volunteers.
Interventions
- DRUG lopinavir/ritonavir
- DRUG rifabutin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00743470
The ClinicalTrials.gov registry entry for NCT00743470 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which lopinavir/ritonavir is the first listed.
NCT00743470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00743470 about?
NCT00743470 is a clinical study titled "A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects". The purpose of this study is to study the safety, tolerability and pharmacokinetics of rifabutin dosing with lopinavir/ritonavir tablets in healthy volunteers.
What is the current status of trial NCT00743470?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2008-08.
What interventions are being tested in trial NCT00743470?
The interventions under investigation include: lopinavir/ritonavir (DRUG), rifabutin (DRUG).
Who is sponsoring clinical trial NCT00743470?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.